Review
Open access
Sep 2026
Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations
This review provides a comprehensive and critical overview of the current evidence regarding selected natural compounds in pancreatic cancer, including apigenin, cannabinoids, curcumin, luteolin, quercetin, resveratrol, vitamin C, and vitamin D, with the aim of supporting the design of future clinical studies and facil...
Alberto Orta, Miguel Ángel Hidalgo-León, C. Lacalle-González et al.
· Frontiers in Pharmacology · 0 citations